BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6223378)

  • 1. Piperacillin therapy for Pseudomonas infections.
    Eron LJ; Goldenberg RI; Poretz DM; Park CH
    South Med J; 1983 Jul; 76(7):859-62. PubMed ID: 6223378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
    Simon GL; Snydman DR; Tally FP; Gorbach SL
    Antimicrob Agents Chemother; 1980 Jul; 18(1):167-70. PubMed ID: 6448020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R; Lee M; Ojeda L; Tabib M
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of piperacillin therapy for infection.
    Pancoast S; Prince AS; Francke EL; Neu HC
    Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent urinary tract infection in children: treatment with amoxicillin.
    Mongeau JG; Mahfoud G
    J Infect Dis; 1974 Jun; 129(0):suppl:S243-5. PubMed ID: 4601341
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbenicillin in treatment of severe infections due to pseudomonas.
    Jordan MC; Standiford HC; Kirby WM
    J Infect Dis; 1970 Sep; 122():Suppl:S96+. PubMed ID: 4319045
    [No Abstract]   [Full Text] [Related]  

  • 8. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").
    Stratford BC
    Med J Aust; 1968 Nov; 2(20):890-5. PubMed ID: 4973410
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbenicillin therapy of severe Pseudomonas aeruginosa infections.
    Solberg CO; Kjellstrand KM; Matsen JM
    J Chronic Dis; 1971 Jun; 24(1):19-28. PubMed ID: 5209072
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and microbiologic studies of carbenicillin.
    Michaeli D; Weinstein L
    J Infect Dis; 1970 Sep; 122():Suppl:S90-5. PubMed ID: 4990026
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticarcillin for treatment of serious infections with gram-negative bacteria.
    Parry MG; Neu HC
    J Infect Dis; 1976 Nov; 134(5):476-85. PubMed ID: 825582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.
    Wise R; Reeves DS
    Chemotherapy; 1974; 20(1):45-51. PubMed ID: 4210893
    [No Abstract]   [Full Text] [Related]  

  • 14. Piperacillin therapy for serious bacterial infections.
    Winston DJ; Murphy W; Young LS; Hewitt WL
    Am J Med; 1980 Aug; 69(2):255-61. PubMed ID: 6447455
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.
    Smith CB; Wilfert JN; Dans PE; Kurrus TA; Finland M
    J Infect Dis; 1970 Sep; 122():Suppl:S14-28. PubMed ID: 4990023
    [No Abstract]   [Full Text] [Related]  

  • 16. Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.
    Pournaras S; Ikonomidis A; Neou E; Kantzanou M; Maniatis AN; Tsakris A
    J Antimicrob Chemother; 2008 Mar; 61(3):757-8. PubMed ID: 18199562
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.
    Prince AS; Neu HC
    J Pediatr; 1980 Jul; 97(1):148-51. PubMed ID: 6445961
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of carbenicillin in pseudomonas infections of the urinary tract.
    Malmborg AS
    Scand J Urol Nephrol; 1969; 3(1):45-9. PubMed ID: 4981898
    [No Abstract]   [Full Text] [Related]  

  • 19. [1st personal experiences with carbenicillin therapy of urinary tract infections due to Pseudomonas aeruginosa].
    De Rosa F
    G Mal Infett Parassit; 1971 Nov; 23(11):1068-70. PubMed ID: 5004854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the anti-Pseudomonas aeruginosa activity of ureidopenicillins and recent advances in their research].
    Li JT
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):332-5. PubMed ID: 2510980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.